Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)

China flag China · Delayed Price · Currency is CNY
8.49
-0.14 (-1.62%)
Jul 30, 2026, 1:34 PM CST
Market Cap3.78B -17.1%
Revenue (ttm)2.47B +3.2%
Net Income16.84M
EPS0.03
Shares Out 438.41M
PE Ratio254.56
Forward PE29.76
Dividend0.30 (3.55%)
Ex-Dividend DateJun 4, 2026
Volume4,911,060
Open8.61
Previous Close8.63
Day's Range8.44 - 8.65
52-Week Range7.89 - 14.37
Beta0.49
Analystsn/a
Price Targetn/a
Earnings DateAug 31, 2026

About SHA:603520

Zhejiang Starry Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients in China and internationally. It operates through Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments. The company offers preparation products comprising iohexol, iopamidol, iodixanol, iodine-methyl, iodophorol, ioflufenicol, iopromide gadoxime meglumine, gadolinate dimeglumine, gadolinium, and iohexol injections; contrast agent APIs and intermediates consisti... [Read more]

Sector Healthcare
Founded 1997
Employees 1,905
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603520
Full Company Profile

Financial Performance

Financial Statements